华昊中天医药-B(02563)：优替德隆4项临床研究成果入选2026年美国临床肿瘤学会(ASCO)年会

智通财经05-27

智通财经APP讯，华昊中天医药-B(02563)发布公告，公司核心产品优替德隆注射液(“UTD1”)及优替德隆胶囊(“UTD2”)的四项最新临床研究数据入选2026年美国临床肿瘤学会(ASCO)年会(“2026 ASCO年会”)，进行壁报展示。本次入选的四项研究分别针对UTD2治疗晚期乳腺癌I/II期临床试验、UTD2治疗铂耐药卵巢癌II期临床试验、UTD1治疗HER2阳性晚期乳腺癌II期临床试验...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2638974689?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-27 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638974689","market":"hk","top_or_hot":-1,"title":"华昊中天医药-B(02563)：优替德隆4项临床研究成果入选2026年美国临床肿瘤学会(ASCO)年会","media":"智通财经","content":"<div>\n<p>智通财经APP讯，华昊中天医药-B(02563)发布公告，公司核心产品优替德隆注射液(“UTD1”)及优替德隆胶囊(“UTD2”)的四项最新临床研究数据入选2026年美国临床肿瘤学会(ASCO)年会(“2026 ASCO年会”)，进行壁报展示。本次入选的四项研究分别针对UTD2治疗晚期乳腺癌I/II期临床试验、UTD2治疗铂耐药卵巢癌II期临床试验、UTD1治疗HER2阳性晚期乳腺癌II期临床试验...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1446899.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华昊中天医药-B(02563)：优替德隆4项临床研究成果入选2026年美国临床肿瘤学会(ASCO)年会</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华昊中天医药-B(02563)：优替德隆4项临床研究成果入选2026年美国临床肿瘤学会(ASCO)年会\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-27 22:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1446899.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，华昊中天医药-B(02563)发布公告，公司核心产品优替德隆注射液(“UTD1”)及优替德隆胶囊(“UTD2”)的四项最新临床研究数据入选2026年美国临床肿瘤学会(ASCO)年会(“2026 ASCO年会”)，进行壁报展示。本次入选的四项研究分别针对UTD2治疗晚期乳腺癌I/II期临床试验、UTD2治疗铂耐药卵巢癌II期临床试验、UTD1治疗HER2阳性晚期乳腺癌II期临床试验...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1446899.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1446899.html","article_id":"2638974689","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638974689","pubTimestamp":1779892799,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，华昊中天医药-B 发布公告，公司核心产品优替德隆注射液及优替德隆胶囊的四项最新临床研究数据入选2026年美国临床肿瘤学会年会，进行壁报展示。本次入选的四项研究分别针对UTD2治疗晚期乳腺癌I/II期临床试验、UTD2治疗铂耐药卵巢癌II期临床试验、UTD1治疗HER2阳性晚期乳腺癌II期临床试验以及UTD1治疗去势抵抗性前列腺癌II期临床试验。2026 ASCO年会将于2026年5月29日至6月2日在美国芝加哥麦考密克会展中心举办。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","09939":"开拓药业-B","BK1515":"抗疫概念","BK1161":"生物科技","02563":"华昊中天医药-B","BK1574":"生物医药B类股"},"translate_title":"Huahao Zhongtian Pharmaceutical-B (02563): Four clinical research results of Utideron were selected for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1.5,"09939":1.5,"02563":1.5},"content_text":"智通财经APP讯，华昊中天医药-B(02563)发布公告，公司核心产品优替德隆注射液(“UTD1”)及优替德隆胶囊(“UTD2”)的四项最新临床研究数据入选2026年美国临床肿瘤学会(ASCO)年会(“2026 ASCO年会”)，进行壁报展示。本次入选的四项研究分别针对UTD2治疗晚期乳腺癌I/II期临床试验、UTD2治疗铂耐药卵巢癌II期临床试验、UTD1治疗HER2阳性晚期乳腺癌II期临床试验以及UTD1治疗去势抵抗性前列腺癌II期临床试验。基于优替德隆抗癌谱广、口服生物利用度高等特性，华昊中天持续在新适应症拓展、口服剂型临床开发等方面深入布局。2026 ASCO年会将于2026年5月29日至6月2日在美国芝加哥麦考密克会展中心举办。一年一度的ASCO年会汇聚来自全球临床肿瘤学的精英，将展示国际最前沿的临床肿瘤学研究成果和肿瘤治疗技术。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638974689","isCrawlerRequest":true}